RISEUPTOHIV
RISEUPTOHIV
EDUCATION • COMMUNITY • RESOURCES
About Contact
ES HT
Quick Answer

What are my HIV risk factors?

Answered in plain language, anchored to CDC, HIV.gov, and NIH.

Last reviewed:

Health information — Educational information, not medical advice. Talk with your healthcare provider about your care and treatment decisions.
← Home
Share this answer Facebook X WhatsApp Text Email LinkedIn Reddit Threads Bluesky

HIV risk depends on an exposure, not an identity. Examples include anal or vaginal sex when HIV is present without effective prevention, and sharing blood-contaminated injection equipment. An STI can modify risk during an exposure but does not itself transmit HIV. PrEP, PEP, condoms, sterile equipment and effective HIV treatment provide prevention options.[1][5][6][12]

Risk is a situation, not an identity

For HIV transmission, an infectious fluid must reach susceptible tissue or the bloodstream. Blood, semen and pre-seminal fluid, vaginal fluid, rectal fluid and breast milk can carry HIV. Ordinary contact with saliva, tears, urine or feces without blood does not transmit HIV. Blood contamination requires a separate exposure assessment.[9][1]

That biology is why “risk group” thinking misleads people. What creates risk is a specific combination of fluid, route, and viral load — not a demographic label. Two people can do the exact same thing and face completely different risk depending on whether HIV is present and whether it is being treated[8].

What actually raises risk, with numbers

CDC’s historical per-10,000 baseline estimates for exposure to a source with HIV include receptive anal sex 138, insertive anal sex 11, receptive vaginal sex 8, insertive vaginal sex 4, needle sharing 63 and percutaneous needlestick 23. They do not account for every prevention measure and should not be used for sex with a partner maintaining viral suppression. Oral sex has little to no HIV risk. Saliva without blood does not transmit HIV.[12][16][2]

Higher viral load and some STIs can increase HIV transmission or acquisition risk when an exposure occurs without effective prevention. CDC’s estimate of a 2.65-fold association between genital ulcers and acquisition comes from observational heterosexual studies; it is not an oral-sex multiplier or a personal risk calculator. Early infection may involve high viral load, but an unknown diagnosis does not establish someone’s viral load. An STI does not undo U=U when suppression below 200 copies/mL is maintained.[12][8][2][9]

Why “high-risk group” language is outdated and harmful

CDC's own stigma guidance names “believing that only certain groups of people can get HIV” as a form of HIV stigma, alongside making moral judgments about people who take prevention steps and feeling that people deserve HIV because of their choices[4]. Stigma is not just unkind. NIAID states plainly that “language-driven stigma prevents people from seeking health services which provide benefit”[10].

Group language also gives false reassurance. HIV.gov notes that HIV “can affect anyone regardless of sexual orientation, race, ethnicity, gender, age, or where they live,” even while epidemiology shows some communities carry a heavier burden because of prevalence in local sexual and injecting networks[11]. The useful takeaway from that data is about context and access, not identity: living where HIV is more common raises the chance that a given partner has HIV[11].

Prevention tools that work in any situation

PrEP options include daily F/TDF (Truvada or generic), daily F/TAF (Descovy), injectable cabotegravir (Apretude) and injectable lenacapavir (Yeztugo). The choice depends on exposure route and health needs: CDC recommends F/TDF for sexual or injection-related exposure; F/TAF is not indicated for receptive vaginal exposure. Cabotegravir has a second injection one month after the first, then every two months. Lenacapavir uses oral initiation doses and injections every six months. These PrEP products are for adults and adolescents weighing at least 35 kg. The injection-drug-use protection estimate of at least 74% comes from oral tenofovir studies and should not be applied to all products.[13][14][5]

PEP is an emergency option after an exposure that warrants treatment: a 28-day course started as soon as possible, ideally within 24 hours and no later than 72 hours. Seek urgent assessment rather than waiting for symptoms or a later routine HIV test.[6]

A partner maintaining HIV RNA below 200 copies/mL on ART does not transmit HIV through sex. Condoms used consistently and correctly reduce exposure, but a single 70–71% estimate does not apply equally to anal and vaginal sex. For injection, use new sterile needles and syringes and do not share other blood-contaminated equipment.[12][7][8][3]

Turning this into a personal plan

Instead of asking “am I in a risk group,” ask three answerable questions.

What exposures are part of my life, and what prevention am I using? What do I know about my partners’ treatment and viral suppression? When did I last test for HIV and other STIs? Talk through these questions with a clinician. CDC recommends offering PrEP to people who request it, even if they do not disclose risk factors. STI screening should fit age, pregnancy, exposures and clinical history rather than one schedule for everyone.[13][15][3][5][1]

Related questions

Does having HIV in my family or community mean I'm at higher risk?

HIV is not inherited as a family trait or spread by household contact. It requires a relevant exposure; ordinary hugging, shared dishes and toilets do not transmit it. Community prevalence can affect the chance of encountering HIV but does not determine any individual’s status.[9][11]

If my partner is undetectable, do I still need PrEP?

A partner maintaining viral load below 200 copies/mL on ART does not transmit HIV through sex. Some people still choose PrEP for other partners or personal reassurance. CDC recommends offering PrEP when requested; a clinician can help select a suitable option.[12][13]

Can I get HIV from oral sex?

Oral sex has much lower HIV risk than anal or vaginal sex. CDC describes little to no risk, and the evidence does not support an exact per-act probability. A confidence interval from a small evidence base should not be treated as your personal risk range.[16]

I think I was exposed last night. What do I do?

Seek PEP assessment now. If indicated, treatment should start as soon as possible, ideally within 24 hours and no later than 72 hours, for 28 days. If more time has passed, still seek testing, clinical advice and a prevention plan.[6]

How is HIV transmitted?
The four documented routes, the per-act numbers, and what does not transmit HIV.
Prevention
PrEP, PEP, condoms, and U=U — every tool, plainly explained.
HIV Testing
Which test to ask for, window periods, and where to test near you.
Undetectable = Untransmittable
The clinical evidence behind U=U and what “undetectable” actually means.
Learning Hub
In-depth explainers on prevention, treatment, and living well with HIV.
Last reviewed: September 2026 by the RiseUpToHIV team. Educational content only — not medical advice.

References & Sources

  1. CDC — How HIV Spreads. Fluids that can carry HIV, routes of entry, and the role of untreated STIs. ↩ ↩ ↩ ↩
  2. CDC — HIV Risk and Prevention Estimates. Per-10,000-exposure risk table plus STI-related risk ratios. ↩ ↩ ↩ ↩
  3. CDC — How HIV Spreads; injection equipment and other exposure routes. Source. ↩↩
  4. CDC — Let's Stop HIV Together: HIV Stigma. Lists “believing that only certain groups of people can get HIV” as HIV stigma. ↩
  5. HIV.gov — Pre-Exposure Prophylaxis (PrEP). All four approved PrEP products, effectiveness figures, and who PrEP is for. ↩ ↩ ↩ ↩ ↩ ↩ ↩
  6. CDC — 2025 nonoccupational PEP guidelines; assessment, timing and duration. Source. ↩ ↩ ↩
  7. NIH — The science is clear: with HIV, undetectable equals untransmittable. Federal statement that a durably undetectable viral load means no sexual transmission. ↩
  8. CDC — HIV Risk and Prevention Estimates; study-specific baseline, viral-load, STI and condom evidence. Source. ↩↩↩
  9. NIH HIVinfo — Understanding How HIV Is Transmitted; infectious fluids and exposure routes. Source. ↩↩↩ ↩
  10. NIAID — Our Words Have Power (HIV Language Guide). Federal guidance on person-first language and the harm of language-driven stigma. ↩
  11. HIV.gov — Who is at risk for HIV?. HIV can affect anyone; community prevalence explains burden, not identity. ↩ ↩ ↩
  12. NIH ARV Guidelines — Treatment as Prevention; sexual U=U threshold and continued suppression. Source. Checked September 21, 2026. ↩ ↩ ↩ ↩ ↩
  13. CDC HIV Nexus — Clinical Guidance for PrEP; medication-specific recommendations and monitoring. Source. Checked September 21, 2026. ↩ ↩ ↩
  14. CDC (2025) — Clinical Recommendation for Injectable Lenacapavir as HIV PrEP. Source. Checked September 21, 2026. ↩
  15. CDC STI Treatment Guidelines — Screening Recommendations by population and exposure site. Source. Checked September 21, 2026. ↩
  16. CDC — About STI Risk and Oral Sex; little to no HIV risk and limitations of estimates. Source. Checked September 21, 2026. ↩ ↩

Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.

Search RiseUpToHIV